Long‐term effects of the <scp>COVID</scp>‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics

Michalowitz, Alena‐Lioba; Kreuter, Alexander; Hofmann, Silke

doi:10.1111/jdv.18337

Cited by 12 publications

(23 citation statements)

References 9 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As reported by Balakirski et al, 4 we did not observe a statistically significant difference in tumour thickness and age of the patients comparing the pre-pandemic years to the pandemic ones.…”

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosissupporting

confidence: 69%

“…1 Recent studies investigated the impact of COVID-19 on melanoma diagnosis highlighting a reduction in melanoma detection. 5,6 However, Balakirski et al 4 experience and ours did not show a statistically significant reduction in melanoma detection comparing pre-pandemic with pandemic years. Certainly, strategies developed in our clinic during the pandemic to overcome the restrictive measures such as telemedicine and informatic support systems in order to increase the awareness of melanoma may explain the absence of a significant reduction in melanoma diagnosis during the pandemic and the increase in melanoma detection in 2021.…”

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosiscontrasting

confidence: 52%

“…1 Restrictive measures adopted during COVID-19 pandemic in order to avoid infection spreading led to a reduction in the number of accesses in dermatologic clinics. 2,3 We read with great interest the article recently written by Balakirski et al 4 evaluating the long-term effect of COVID-19 pandemic on the detection and dermatosurgical treatment of melanoma, and we also want to report the experience of our third-level centre for 'Melanoma Diagnosis and Prevention.…”

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosismentioning

confidence: 99%

See 2 more Smart Citations

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

Villani

Scalvenzi

Fabbrocini

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosissupporting

confidence: 69%

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosiscontrasting

confidence: 52%

Section: Effects Of Covid-19 Pandemic On Malignant Melanoma Diagnosismentioning

confidence: 99%

See 1 more Smart Citation

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

Villani

Scalvenzi

Fabbrocini

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

“…The study selection process is summarized in Figure 1 . From a total of 466 records, 25 studies were incorporated in our data analysis models [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ].…”

Section: Resultsmentioning

confidence: 99%

A Meta-Analysis on the Impact of the COVID-19 Pandemic on Cutaneous Melanoma Diagnosis in Europe

Seretis

Bounas

Gaitanis

et al. 2022

Cancers

View full text Add to dashboard Cite

The COVID-19 pandemic has been the epicenter of healthcare attention globally for the past two years, and large-scale adaptations in healthcare provision have been required. This study aimed to investigate the impact of the pandemic and the resulting lockdowns on cutaneous melanoma diagnosis and tumor burdens in Europe. A relevant literature search in electronic databases was conducted from inception to September 2022. The inclusion criteria were: controlled studies published in a peer-reviewed journal evaluating cutaneous melanoma in Europe and reporting data on melanoma characteristics from diagnoses. The quality of studies was evaluated using the Cochrane ROBINS-I tool for assessing bias in non-randomized studies. Meta-analysis was conducted utilizing a random effects model to synthesize the data. A total of 25 studies involving 32,231 patients were included in the data analysis models. Statistically significant increases in mean Breslow thickness (0.29 mm (0.03–0.55 mm)), ulceration rates (OR = 1.66 (1.29–2.13)), and resultant tumor staging were observed in the PostCovid group, with subgroup analysis revealing that lockdown-derived data were responsible for this trend. This meta-analysis reported on the impact of COVID-19 restrictions on melanoma diagnosis in Europe, emphasizing the higher tumor burden and disease progression state provoked by healthcare adaptations in the pandemic period.

show abstract

“…A recent publication from Germany is consistent with the answers of the survey respondents that the number of newly diagnosed malignant melanomas did not decrease in both 2020 and 2021 compared to 2019 and that tumor thickness or tumor stages remained stable, as well. 21 However, an increase in positive sentinel lymph nodes has been described, indicating a delay either during diagnosis or in surgical therapy. 21 In Germany, epithelial and melanocytic tumors admitted to hospital for surgical treatment represent the most common dermatological inpatient diagnoses.…”

Section: None Receivedmentioning

confidence: 99%

Effects of the COVID‐19 pandemic on inpatient skin surgery in Germany: results of the DESSI‐survey

Balakirski,

Hofmann,

Isselmann

et al. 2023

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Background:The aim of the survey was to investigate a possible impairment of inpatient dermatological and dermatosurgical care in Germany due to the COVID-19 pandemic. Methods: An online survey on the impact of pandemic-related measures on inpatient care was sent to all German dermatology clinics. Only one person per clinic was asked to participate. Data analysis was mainly descriptive. Differences between university hospitals and non-university hospitals were calculated using the Chi-square test. Results: From the 113 dermatological clinics with inpatient care, we received 45 (39.8%) at least partially completed questionnaires. Of these, 25 (55.6%) came from university hospitals, 18 (40.0%) from teaching hospitals of a university, 1 (2.2%) from a non-teaching hospital, and 1 (2.2%) from a participant who did not provide any information on his facility. More than half of survey participants (57.8%) reported that many elective skin surgeries had to be canceled at their clinics at the beginning of the COVID-19 pandemic. However, most of the clinics (75.6%) were able to perform medically necessary surgeries (such as for malignant melanoma). Only 28.9% (13/45) of participants reported that skin surgery in their clinics returned to full strength after the COVID-19 pandemic. There was no statistically significant difference between university hospitals and non-university hospitals regarding the influence of COVID-19-related restrictions. Conclusions: Despite their heterogeneity, the results of the survey show an overall clear and long-term pandemic-related impairment of inpatient dermatology and skin surgery in Germany.

show abstract

Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics

Cited by 12 publications

References 9 publications

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

A Meta-Analysis on the Impact of the COVID-19 Pandemic on Cutaneous Melanoma Diagnosis in Europe

Effects of the COVID‐19 pandemic on inpatient skin surgery in Germany: results of the DESSI‐survey

Contact Info

Product

Resources

About